Literature DB >> 14064792

THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.

F WOEHLER.   

Abstract

Entities:  

Keywords:  ANEMIA, MACROCYTIC; DEFEROXAMINE; DIABETES MELLITUS; FERRITIN; HEMOCHROMATOSIS; HEMOGLOBIN; HEMOSIDEROSIS; HYDROXAMIC ACID; IRON; IRON ISOTOPES; LIVER CIRRHOSIS; THALASSEMIA; TRANSFERRIN; URINE

Mesh：

Substances：

Year:  1963        PMID： 14064792     DOI： 10.1159/000208110

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  9 in total

1.  [EFFECT OF DESFERRIOXAMINE ON LIVER SEGMENTS IN HEMOCHROMATOSIS].

Authors:  M KNOBLAUCH
Journal:  Klin Wochenschr       Date:  1965-03-01

2.  MANAGEMENT OF ACUTE IRON POISONING.

Authors:  D M BURLEY; J FIELDING
Journal:  Br Med J       Date:  1965-04-10

3.  Desferrioxamine in thalassaemia.

Authors:  M Diwany; M Gabr; A el Hefni; N Mokhtar
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

4.  [The effect of deferoxamine B on the blood sugar behavior in intravenous glucose loading in healthy persons].

Authors:  M Brodanová; V Hoenig; V Brodan; J Válek; E Kuhn
Journal:  Klin Wochenschr       Date:  1967-02-01

Review 5.  Chalkophores.

Authors:  Grace E Kenney; Amy C Rosenzweig
Journal:  Annu Rev Biochem       Date:  2018-04-18       Impact factor: 23.643

Review 6.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Effects of desferrioxamine in patients with iron-loading with a simple method for estimating urinary iron.

Authors:  M S Losowsky
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411

8.  Ferritin iron uptake and release. Structure-function relationships.

Authors:  P M Harrison; T G Hoy; I G Macara; R J Hoare
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

9.  Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Authors:  Satoru Oshiro; Masaki S Morioka; Masataka Kikuchi
Journal:  Adv Pharmacol Sci       Date:  2011-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.